IGNT NEWS
looks hot IMO...definitely worth keeping an eye on, should do well today... Ingen Enters Hospital and Therapy Markets With Expected Revenue IncreaseCEO Live Radio Broadcast Talks About These New Markets
- Press Release
- Source: Ingen Technologies, Inc.
- On 4:15 pm EST, Friday November 20, 2009
- Buzz up! 0
- Companies:
YUCAIPA, Calif., Nov. 20, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the company is now marketing direct to the hospital and therapy respiratory markets. Ingen's CEO, Scott Sand, will discuss these new markets this coming Tuesday, November 24, 2009 at 11:34AM eastern standard time on The Money Channel's American Scene Radio with host Steve Crowley. Related QuotesSymbolPriceChangeIGNT.PK0.0029+0.0001 {"s" : "ignt.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""} According to the most recent report published in June 2009 and made available on the Global Market Research Information Network, respiratory market revenues are high currently, with good potential for sales increases. As the patient population grows and respiratory diseases become more prevalent, the market has the potential for continued growth in many countries and therapeutic areas. There is a great demand for products that provide therapeutic and commercial benefits in this demanding and competitive market. The developing markets of Asia, Latin America and Europe will drive sales increases in particular. The company is introducing its new Oxyview Nasal Cannula at the America Association of Respiratory Care (AARC) on December 5 - 7, 2009 as an exhibitor. There are 47,000 members of AARC who are hospital based clinicians, therapists and managers, and a large majority will be attending this annual meeting in San Antonio, Texas. "Our focus has been home health care markets and this is going very smoothly with an increase in sales from home oxygen patients and oxygen providers. Our GSA application is expected to be approved in the near future, and with the growing hospital markets in respiratory care, the Oxyview Nasal Cannula will be an attractive device for hospital nursing as it has shown to save time and provide additional assurance of oxygen flow. Our near final ISO Certification expected in late December 2009 and our recent issue/publication of our patent in the People's Republic of China is in alignment with the future demand for our Oxyview Nasal Cannula in various export countries according to the most recent studies," stated Scott Sand, Chief Executive Officer and Chairman of the Board.
Ignt a strong buy today. News came out this morning. Keep this stock on your radar list. I am currently going to take a position with a few other investors on this company. A good time to buy this stock while the price is low. I expect this stock to break through the 20 day ma of .0021 and bounce hold at the 50 day ma of .0026. good luck to you all!!
Thanks for the new news! Interest in this company continues to be progressive. Imo, once the GSA contract is solidified there will be no stopping this company!!!
IGNT: Ingen Technologies, Inc.This stock is really taking off today!!! IMO this is a great one to keep on your radar folks!!! The chart is also looking really promising showing great signs of an upward swing for all investors!!!
IGNT - Tradeing with high volume today!!!This is one to watch!!! RSI LINE approaching Bullish - Mac D running evenThis leading medical device manufacture that is focused on the $4B respiratory market with their oxyview products for the growing ageing population & emerging markets for home.A growing elderly popuulation increase in home oxygen therapy & surgeries, & an increase in chronic obstructive pulmonary dieseases in the USA has resulted in an increase of buyers for Ingen’s new Oxyview Nasal Cannula. Now provides models for adults, pediatrics & infants.The Oxyview Nasal Cannula is the only oxygen cannula in the world with a flow meter built-in that provides extremely accurate flow readings.
2010 Looks to be a Big Year for Ingen TechnologiesThe Company Expects More Distributors, in the U.S. and Abroad, to Pick Up Oxyview
Press Release Source: Ingen Technologies, Inc. On Thursday January 14, 2010, 2:00 pm YUCAIPA, Calif., Jan. 14, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading manufacturer of respiratory medical devices, recently announced that they will engage Medical Strategies International (MSI) to increase sales of the Oxyview product line through GPO contracts. MSI specializes in helping companies increase sales through Group Purchasing Organizations (GPOs), Integrated Delivery Networks (IDNs), and Equipment Planners. Medical Strategies International (MSI) is a strategic business-consulting firm focused on the Medical industry. MSI's Executive Team is highly trained healthcare professionals with over 70 years experience in the Sales, Marketing, Government and Corporate Account Management of medical products and services. Our goal is to assist companies that manufacture or distribute products and services to the Hospital/Physician market and help them increase sales through the extremely important arena of Healthcare Group Purchasing Organizations and Integrated Health Delivery Networks. In the United States, a healthcare group purchasing organization (or GPO) is an entity that is created to leverage the purchasing power of a group of hospitals to obtain discounts from vendors based on the collective buying power of the GPO members. Group purchasing is used in many industries to purchase raw materials and supplies, but it is common practice in the health care industry. The Oxyview Nasal Cannula has garnered a lot of attention at several conventions throughout the world. This showing captured the attention of many distributors who are interested in this new medical technology, opening the doors to the possibility that Oxyview will become available worldwide to patients outside of the United States by March of 2010. Ingen recently unveiled its latest in medical respiratory equipment; the new Oxyview Pulse Oximeter. In 2010, the adult nasal cannula manufacturer plans to aggressively market its medical devices to hospitals. But Ingen's bold plans for growth don't end here. The company also hopes to work with distributors to make the Oxyview product line available worldwide beginning in March-2010. Recently, at the MEDICA convention in Germany, Ingen's showcase of Oxyview earned the company attention from multiple distributors that were on hand for the event. "We look forward to working with Ken Kuiper of Medical Strategies International. Our plan is to capture the VA Hospital market with our expected GSA approval, and capture the commercial hospital market through GPO contracts. The Oxyview Nasal Cannula and the Oxyview Pulse Oximeter will be a great improvement to oxygen therapy in the hospital setting," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.